For in vitro diagnostic use. Others Elecsys IL-6 IVD Elecsys® IL-6 CPS_000490 09015604190 IL 6 Elecsys cobas e 100 V2 Elecsys IL-6 07613336172193 Reagents, kits 100 tests cobas e 411/601/602 true 07027532190 IL 6 Elecsys E2G 100 Elecsys IL-6 04015630940455 Reagents, kits 100 tests cobas e 402/801 true 05109442190 IL 6 Elecsys cobas e 100 Elecsys IL-6 04015630924226 Reagents, kits 100 tests cobas e 411/601/602 true 05109442191 IL 6 Elecsys cobas e 100 RUO Elecsys IL-6 07613336121689 Reagents, kits 100 tests cobas e 411/601/602 true 09015612190 IL 6 Elecsys E2G 100 V2 Elecsys IL-6 07613336172209 Reagents, kits 100 tests cobas e 402/801 true 09015604500 Elecsys IL-6 en 2 FF0000000481D40E FF0000000432650E 09015604190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of Interleukin‑6 (IL‑6) in serum and plasma. This assay can be used to aid in the management of critically ill patients as early indicator for acute inflammation.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015604500 Elecsys IL-6 en 3 FF0000000628B70E FF0000000628B70E 09015604190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys IL-6 is an immunoassay for the in vitro quantitative determination of Interleukin‑6 (IL‑6) in human serum and plasma. It is intended for use in conjunction with clinical evaluation to aid in:management of critically ill patients as an early indicator for acute inflammationdiagnosis of sepsis in neonates with suspected or confirmed bacterial infectionThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027532500 Elecsys IL-6 en 4 FF00000004A41C0E FF00000001AC490E 07027532190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of Interleukin‑6 (IL‑6) in serum and plasma. This assay can be used to aid in the management of critically ill patients as early indicator for acute inflammation.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07027532501 Elecsys IL-6 en 1 FF000000041D110E FF000000041D110E 07027532190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys IL‑6 immunoassay is an in vitro diagnostic test for the quantitative determination of IL‑6 (interleukin‑6) in human serum and plasma. This assay is used to assist in identifying severe inflammatory response in patients with confirmed COVID‑19 illness to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.The Elecsys IL‑6 immunoassay is an electrochemiluminescence immunoassay “ECLIA” and is intended for use on cobas e immunoassay analyzers.The Elecsys IL‑6 immunoassay is only for use under the Food and Drug Administration’s Emergency Use Authorization. For use by health care providers. For prescription use only. For in vitro diagnostic use only. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate and high complexity tests. en 05109442500 Elecsys IL-6 en 10 FF00000004BE7B0E FF000000000FDA0E 05109442190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of Interleukin‑6 (IL‑6) in serum and plasma. This assay can be used to aid in the management of critically ill patients as early indicator for acute inflammation.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 05109442501 Elecsys IL-6 en 1 FF000000041CF90E FF000000041CF90E 05109442190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys IL‑6 immunoassay is an in vitro diagnostic test for the quantitative determination of IL‑6 (interleukin‑6) in human serum and plasma. This assay is used to assist in identifying severe inflammatory response in patients with confirmed COVID‑19 illness to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.The Elecsys IL‑6 immunoassay is an electrochemiluminescence immunoassay “ECLIA” and is intended for use on cobas e immunoassay analyzers.The Elecsys IL‑6 immunoassay is only for use under the Food and Drug Administration’s Emergency Use Authorization. For use by health care providers. For prescription use only. For in vitro diagnostic use only. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate and high complexity tests. en 09015612500 Elecsys IL-6 en 6 FF0000000687860E FF0000000479F60E 09015612190 09015612214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys IL‑6 is an immunoassay for the in vitro quantitative determination of Interleukin‑6 (IL‑6) in human serum and plasma. It is intended for use in conjunction with clinical evaluation to aid in:management of critically ill patients as an early indicator for acute inflammationdiagnosis of sepsis in neonates with suspected or confirmed bacterial infectionThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en